• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Editorial: The effects of COVID-19 on cancer research methods & strategies.社论：2019冠状病毒病对癌症研究方法及策略的影响
Front Public Health. 2022 Aug 10;10:988736. doi: 10.3389/fpubh.2022.988736. eCollection 2022.
2
SARS-CoV-2/COVID-19, Lymphatic vessels, lymph, and lymphology.严重急性呼吸综合征冠状病毒2型/冠状病毒病、淋巴管、淋巴液与淋巴学
Lymphology. 2020;53(3):97-98.
3
Editorial: Impact of COVID-19 on the clinical microbiology laboratory: Preparing for the next pandemic.社论：2019冠状病毒病对临床微生物学实验室的影响：为下一次大流行做准备
Front Cell Infect Microbiol. 2022 Sep 20;12:1031436. doi: 10.3389/fcimb.2022.1031436. eCollection 2022.
4
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益（CoV-Surv 研究）：一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
5
Editorial - Cancer patients and COVID-19: history repeats itself.社论——癌症患者与新冠肺炎：历史重演。
Eur Rev Med Pharmacol Sci. 2022 Jul;26(14):4949-4950. doi: 10.26355/eurrev_202207_29279.
6
Editorial: Immunometabolic mechanisms underlying the severity of COVID-19.社论：新冠病毒疾病严重程度背后的免疫代谢机制
Front Immunol. 2022 Jul 20;13:977907. doi: 10.3389/fimmu.2022.977907. eCollection 2022.
7
COVID-19 outcomes in patients with cancer: Findings from the University of California health system database.癌症患者的 COVID-19 结局：来自加利福尼亚大学健康系统数据库的研究结果。
Cancer Med. 2022 Jun;11(11):2204-2215. doi: 10.1002/cam4.4604. Epub 2022 Mar 9.
8
Preexisting and Post-COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer.癌症患者对 SARS-CoV-2 的预先存在和 COVID-19 后免疫反应。
Cancer Discov. 2021 Aug;11(8):1982-1995. doi: 10.1158/2159-8290.CD-21-0191. Epub 2021 May 19.
9
Progress in understanding COVID-19: insights from the omics approach.对 COVID-19 的认识进展：组学方法的启示。
Crit Rev Clin Lab Sci. 2021 Jun;58(4):242-252. doi: 10.1080/10408363.2020.1851167. Epub 2020 Dec 29.
10
Editorial: Impact of the Covid-19 Pandemic on Breast Cancer Treatment and Patient Experience.社论：2019冠状病毒病大流行对乳腺癌治疗及患者体验的影响
Ann Surg Oncol. 2022 Mar;29(3):1502-1503. doi: 10.1245/s10434-021-11227-z. Epub 2022 Jan 2.

本文引用的文献

1
COVID-19 2022 update: transition of the pandemic to the endemic phase.COVID-19 2022 更新：大流行向地方病阶段的过渡。
Hum Genomics. 2022 Jun 1;16(1):19. doi: 10.1186/s40246-022-00392-1.
2
Association between COVID-19 burden and delays to diagnosis and treatment of cancer patients in England.英国新冠疫情负担与癌症患者诊断和治疗延误之间的关联。
J Cancer Policy. 2022 Mar;31:100316. doi: 10.1016/j.jcpo.2021.100316. Epub 2021 Dec 8.
3
Risk and Outcome of Breakthrough COVID-19 Infections in Vaccinated Patients With Cancer: Real-World Evidence From the National COVID Cohort Collaborative.接种疫苗的癌症患者中新冠病毒突破性感染的风险与结局：来自国家新冠队列协作组的真实世界证据
J Clin Oncol. 2022 May 1;40(13):1414-1427. doi: 10.1200/JCO.21.02419. Epub 2022 Mar 14.
4
Cancer Services During the COVID-19 Pandemic: Systematic Review of Patient's and Caregiver's Experiences.COVID-19大流行期间的癌症服务：对患者和护理人员经历的系统评价
Cancer Manag Res. 2021 Jul 29;13:5875-5887. doi: 10.2147/CMAR.S318115. eCollection 2021.
5
Outcomes of COVID-19 in Patients With Cancer: Report From the National COVID Cohort Collaborative (N3C).COVID-19 患者的癌症结局：来自国家 COVID 队列协作 (N3C) 的报告。
J Clin Oncol. 2021 Jul 10;39(20):2232-2246. doi: 10.1200/JCO.21.01074. Epub 2021 Jun 4.
6
Health systems resilience in managing the COVID-19 pandemic: lessons from 28 countries.应对 COVID-19 大流行的卫生系统韧性：28 个国家的经验教训。
Nat Med. 2021 Jun;27(6):964-980. doi: 10.1038/s41591-021-01381-y. Epub 2021 May 17.
7
The impact of national non-pharmaceutical interventions ('lockdowns') on the presentation of cancer patients.国家非药物干预措施（“封锁”）对癌症患者就诊情况的影响。
Ecancermedicalscience. 2021 Feb 3;15:1180. doi: 10.3332/ecancer.2021.1180. eCollection 2021.
8
Review on the Oncology Practice in the Midst of COVID-19 Crisis: The Challenges and Solutions.COVID-19 危机中的肿瘤学实践综述：挑战与解决方案。
Asian Pac J Cancer Prev. 2021 Jan 1;22(1):19-24. doi: 10.31557/APJCP.2021.22.1.19.
9
Mortality due to cancer treatment delay: systematic review and meta-analysis.癌症治疗延迟导致的死亡率：系统评价与荟萃分析
BMJ. 2020 Nov 4;371:m4087. doi: 10.1136/bmj.m4087.
10
The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study.《COVID-19 大流行对英国英格兰因诊断延误导致的癌症死亡人数的影响：一项全国性基于人群的建模研究》。
Lancet Oncol. 2020 Aug;21(8):1023-1034. doi: 10.1016/S1470-2045(20)30388-0. Epub 2020 Jul 20.

Editorial: The effects of COVID-19 on cancer research methods & strategies.

作者信息

Fox Louis, Sullivan Richard, Mukherji Deborah, Van Hemelrijck Mieke

机构信息

King's College London, London, United Kingdom.

Lebanese American University, Beirut, Lebanon.

出版信息

Front Public Health. 2022 Aug 10;10:988736. doi: 10.3389/fpubh.2022.988736. eCollection 2022.

DOI:10.3389/fpubh.2022.988736
PMID:36033807
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9400378/
Abstract
摘要